Repression of transcriptional activity of estrogen receptor α by a cullin3/SPOP ubiquitin E3 ligase complex

Molecules and Cells

Volumn 25, Issue 2, 2008, Pages 289-293

  Byun, Boohyeong ^a   Jung, Yunhwa ^b  

^a Daegu Haany University   (South Korea)

^b Korea Advanced Institute of Science and Technology (KAIST)   (South Korea)

Author keywords

Cullin3 based E3 ubiquitin ligase complex; ER ; SPOP; Ubiquitination

Indexed keywords

ESTROGEN RECEPTOR ALPHA; UBIQUITIN PROTEIN LIGASE E3;

AMINO TERMINAL SEQUENCE; ARTICLE; CELL CULTURE; CELL STRAIN HEK293; CONTROLLED STUDY; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MAMMAL CELL; PROTEIN DOMAIN; TRANSACTIVATION; UBIQUITINATION;

CELL LINE; CULLIN PROTEINS; ESTROGEN RECEPTOR ALPHA; HUMANS; PROTEIN BINDING; REPRESSOR PROTEINS; TRANS-ACTIVATION (GENETICS); TRANSCRIPTION, GENETIC; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

MAMMALIA;

EID: 44949254090     PISSN: 10168478     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Alarid, E.T., Preisler-Mashek, M.T., and Solodin, N.M. (2003). Thyroid hormone is an inhibitor of estrogen-induced degradation of estrogen receptor-alpha protein: estrogen-dependent proteolysis is not essential for receptor transactivation function in the pituitary. Endocrinology 144, 3469-3476.
2. Fan, M., Nakshatri, H., and Nephew, K.P. (2004). Inhibiting proteasomal proteolysis sustains estrogen receptor-alpha activation. Mol. Endocrinol 18, 2603-2615.
3. Hernandez-Munoz, I., Lund, A.H., van der Stoop, P., Boutsma, E., Muijrers, I., Verhoeven, E., Nusinow, D.A., Panning, B., Marahrens, Y., and van Lohuizen, M. (2005). Stable X chromosome inactivation involves the PRC1 Polycomb complex and requires histone MACROH2A1 and the CULLIN3/ SPOP ubiquitin E3 ligase. Proc. Natl. Acad. Sci. USA 102, 7635-7640.
4. Ikeda, K., and Inoue, S. (2004). Estrogen receptors and their downstream targets in cancer. Arch. Histol. Cytol. 67, 435-442.
5. Kim, S.H., Lee, S.U., Kim, M.H., Kim, B.T., and Min, Y.K. (2005). Mitogenic estrogen metabolites alter the expression of 17beta-estradiol-regulated proteins including heat shock proteins in human MCF-7 breast cancer cells. Mol. Cells 20, 378-384.
6. Kobayashi, A., Kang, M.I., Okawa, H., Ohtsuji, M., Zenke, Y., Chiba, T., Igarashi, K., and Yamamoto, M. (2004). Oxidative stress sensor Keap1 functions as an adaptor for Cul3-based E3 ligase to regulate proteasomal degradation of Nrf2. Mol. Cell. Biol. 24, 7130-7139.
7. Kwon, J.E., La, M., Oh, K.H., Oh, Y.M., Kim, G.R., Seol, J.H., Baek, S.H., Chiba, T., Tanaka, K., Bang, O. S., et al. (2006). BTB domain-containing speckle-type POZ protein (SPOP) serves as an adaptor of Daxx for ubiquitination by Cul3-based ubiquitin ligase. J. Biol. Chem. 281, 12664-12672.
8. La, M., Kim, K., Park, J., Won, J., Lee, J.H., Fu, Y.M., Meadows, G.G., and Joe, C.O. (2004). Daxx-mediated transcriptional repression of MMP1 gene is reversed by SPOP. Biochem. Biophys. Res. Commun. 320, 760-765.
9. Leclercq, G., Lacroix, M., Laios, I., and Laurent, G. (2006). Estrogen receptor alpha: impact of ligands on intracellular shuttling and turnover rate in breast cancer cells. Curr. Cancer Drug Targets 6, 39-64.
10. Lonard, D.M., Nawaz, Z., Smith, C.L., and O'Malley, B.W. (2000). The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation. Mol. Cell 5, 939-948.
11. Marsaud, V., Gougelet, A., Maillard, S., and Renoir, J.M. (2003). Various phosphorylation pathways, depending on agonist and antagonist binding to endogenous estrogen receptor alpha (ERalpha), differentially affect ERalpha extractability, proteasome-mediated stability, and transcriptional activity in human breast cancer cells. Mol. Endocrinol. 17, 2013-2027.
12. Metzger, D., Berry, M., Ali, S., and Chambon, P. (1995). Effect of antagonists on DNA binding properties of the human estrogen receptor in vitro and in vivo. Mol. Endocrinol. 9, 579-591.
13. Nagai, Y., Kojima, T., Muro, Y., Hachiya, T., Nishizawa, Y., Wakabayashi, T., and Hagiwara, M. (1997). Identification of a novel nuclear speckle-type protein, SPOP. FEBS Lett. 418, 23-26.
14. Nawaz, Z., Lonard, D.M., Dennis, A.P., Smith, C.L., and O'Malley, B.W. (1999). Proteasome-dependent degradation of the human estrogen receptor. Proc. Natl. Acad. Sci. USA 96, 1858-1862.
15. Pintard, L., Willems, A., and Peter, M. (2004). Cullin-based ubiquitin ligases: Cul3-BTB complexes join the family. EMBO J. 23, 1681-1687.
16. Reid, G., Hubner, M.R., Metivier, R., Brand, H., Denger, S., Manu, D., Beaudouin, J., Ellenberg, J., and Gannon, F. (2003). Cyclic, proteasome-mediated turnover of unliganded and liganded ERalpha on responsive promoters is an integral feature of estrogen signaling. Mol. Cell 11, 695-707.
17. Schaefer, H., and Rongo, C. (2006). KEL-8 is a substrate receptor for CUL3-dependent ubiquitin ligase that regulates synaptic glutamate receptor turnover. Mol. Biol. Cell 17, 1250-1260.
18. Scholl, S., and Lippman, M.E. (1984). The estrogen receptor in MCF-7 cells: evidence from dense amino acid labeling for rapid turnover and a dimeric model of activated nuclear receptor. Endocrinology 115, 1295-1301.
19. Shoker, B.S., Jarvis, C., Clarke, R.B., Anderson, E., Hewlett, J., Davies, M.P., Sibson, D.R., and Sloane, J.P. (1999). Estrogen receptor-positive proliferating cells in the normal and pre-cancerous breast. Am J. Pathol. 155, 1811-1815.
20. Wilkins, A., Ping, Q., and Carpenter, C.L. (2004). RhoBTB2 is a substrate of the mammalian Cul3 ubiquitin ligase complex. Genes Dev. 18, 856-861.